Latest News



€8.7 Million Investment Filtered into Novate Medical

20 May, 2011 – GALWAY, Ireland: Novate Medical Ltd., a privately-held development stage medical device company, has secured a Series B investment of €8.7 million co-led by Crédit Agricole Private Equity, based in Paris and venture capital firm Seroba Kernel Life Sciences, based in Dublin. The investment will be used to finance the clinical development of Novate's lead...


Covagen nominates Franz Hefti as new member of the Board of Directors

16 May, 2011 – Zürich-Schlieren, Switzerland: Covagen announced today the nomination of Dr. Franz Hefti to its Board of Directors. Franz Hefti is currently Chief Scientific Officer of Avid Radiopharmaceuticals (Philadelphia, US), a company pioneering the development of imaging agents for neurodegenerative diseases. After successfully completing Phase III clinical trials...


< back to home page